Implicações Cardiovasculares na Covid-19: Uma Revisão Sistemática / Cardiovascular Implications in Covid-19: A Systematic Review
DOI:
https://doi.org/10.34117/bjdv6n10-588Keywords:
COVID-19, Fisiopatologia, Clínica, Cardiovascular, Cardiopatias.Abstract
INTRODUÇÃO: A infecção pelo SARS-CoV-2 tem sido associada à múltiplas repercussões clínicas, descritas em diversos órgãos e sistemas. A associação entre a COVID-19 e o acometimento do sistema cardiovascular ainda é pouco documentada, bem como as suas possíveis consequências. METODOLOGIA: Foi conduzida uma revisão sistemática da literatura. As buscas foram realizadas no mês de agosto de 2020, na base de dados National Library of Medicine (MEDLINE). Os descritores utilizados foram: "COVID-19" [Supplementary Concept] e "Cardiovascular Diseases"[Mesh]. Inicialmente foram encontrados 70 artigos e, após a análise dos resumos e da aplicação dos critérios de inclusão e exclusão, 25 artigos foram selecionados. Foi realizada a busca continuada nas referências dos artigos encontrados, resultando em um escopo final de 27 artigos. Por fim, os estudos foram submetidos à análise quantitativa e qualitativa, resultando em 20 artigos que estão incluídos nesta revisão sistemática. A escala de sistematização PRISMA foi utilizada a fim de aprimorar os resultados desta revisão. RESULTADOS: Os estudos demonstraram que a ocorrência de manifestações cardiovasculares inclui complicações tromboembólicas, elevação dos marcadores cardíacos e afecção miocárdica. Entretanto, diversos estudos apresentam limitações como dificuldade na obtenção de dados, escassez de recursos e curto tempo de acompanhamento. CONCLUSÃO: Apesar dos resultados encontrados e das evidências disponíveis, a condução de novos estudos ainda é necessária para esclarecer o envolvimento cardiovascular na COVID-19.
References
AL-SAMKARI H, KARP LEAF RS, DZIK WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood, v. 136, n 4. p. 489-500, 2020.
ARTIFONI M, DANIC G, GAUTIER G, et al. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J Thromb Thrombolysis, v 50, n 1. p. 211-216, 2020.
DENG Q, HU B, ZHANG Y, et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int J Cardiol, v. 311. p. 116-121, 2020.
GAO C, CAI Y, ZHANG K, et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J, v. 41, n 22. p. 2058-2066, 2020.
GATTO M, PERRICONE C, TONELLO M, et al. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases. Clin Exp Rheumatol, v. 38, n 4. p. 754-759, 2020.
GIL-RODRIGO A, MIRÓ Ò, PIÑERA P, et al. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments. Emergencias, v. 32, n 4. p. 233-241, 2020.
GOSHUA G, PINE AB, MEIZLISH ML, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol, v. 7, n 8. e575-e582, 2020.
HELMS J, TACQUARD C, SEVERAC F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med, v. 46, n 6. p. 1089-1098, 2020.
LALA A, JOHNSON KW, JANUZZI JL, et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol, v. 76, n 5. p. 533-546, 2020.
LLITJOS JF, LECLERC M, CHOCHOIS C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost, v. 18, n 7. p. 1743-1746, 2020.
MCCULLOUGH SA, GOYAL P, KRISHNAN U, CHOI JJ, SAFFORD MM, OKIN PM. Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes. J Card Fail, v. 26, n 7. p. 626-632, 2020.
MORASSI M, BAGATTO D, COBELLI M, et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol, v. 267, n 8. p. 2185-2192, 2020.
PAVONI V, GIANESELLO L, PAZZI M, STERA C, MECONI T, FRIGIERI FC. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis, v. 50, n 2. p. 281-286, 2020.
SALEH M, GABRIELS J, CHANG D, et al. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. Circ Arrhythm Electrophysiol, v. 13, n 6. e008662, 2020.
SHI S, QIN M, SHEN B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol, v. 5, n 7. p. 802–810, 2020.
SONG J, HU W, YU Y, et al. A Comparison of Clinical Characteristics and Outcomes in Elderly and Younger Patients with COVID-19. Med Sci Monit, v. 26, e925047, 2020.
VERDONI L, MAZZA A, GERVASONI A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet, v. 395, n 10239. p. 1771-1778, 2020.
VICENZI M, DI COSOLA R, RUSCICA M, et al. The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients. Eur Respir J, v. 56, n 1. 2001157, 2020.
VOICU S, BONNIN P, STÉPANIAN A, et al. High Prevalence of Deep Vein Thrombosis in Mechanically Ventilated COVID-19 Patients. J Am Coll Cardiol, v. 76, n 4. p. 480-482, 2020.
ZHANG P, ZHU L, CAI J, et al. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circ Res, v. 126, n 12. p. 1671-1681, 2020.
